NCT02526290View on ClinicalTrials.gov

Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Dry Eye SyndromesKeratoconjunctivitis Sicca
Interventions
DEVICE

Intranasal Lacrimal Neurostimulator (Oculeve)

Neurostimulation device

Trial Locations (3)

38119

Total Eye Care, Memphis

85032

Cornea & Cataract Consultants of Arizona, Phoenix

01810

Andover Eye Associates, Andover

Sponsors

Lead Sponsor

Oculeve, Inc.
All Listed Sponsors
lead

Oculeve, Inc.

INDUSTRY